SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Red Cat Holdings, Inc. provides products, services and solutions to the drone industry. It also engages in the provision of distributed data storage, analytics and services for the drone industry.The firm product include Dronebox, which is a blockchain technology that records, stores and analyzes flight data and information from a drone. It operates through the Enterprise Segment. The Enterprise Segment will focus on developing a hardware enabled software platform of services and solutions to government and commercial enterprises and the military. The company was founded by Jeffrey M. Thompson in February 1984 and is headquartered in San Juan, Puerto Rico.

Red Cat Holdings Inc

Red Cat Holdings is generating significant investor buzz and high volatility following the implementation of major US tariffs on foreign drones, a move the community views as a substantial competitive tailwind for the company's American-made systems. Investors are closely monitoring the latest quarterly results and management's forward-looking statements regarding upcoming contract opportunities and production scale as the primary catalysts for potential price movement.

Applied Materials, Inc. engages in provision of materials engineering solutions used to produce semiconductors. The firm also focuses on design, development, production, and servicing of the critical wafer fabrication tools used for customers to manufacture semiconductors. It operates through the following segments: Semiconductor Systems and Applied Global Services (AGS). The Semiconductor Systems segment includes designing, development, manufacturing and sale of equipment used to fabricate semiconductor chips referred to as integrated circuits. The AGS segment engages in provision of services, spares, and factory automation software to customer fabrication plants globally. The company was founded on November 10, 1967 and is headquartered in Santa Clara, CA.

Applied Materials Inc.

Applied Materials is currently trending as investors weigh strong fiscal quarterly earnings and robust forward guidance against market-wide pressure on the semiconductor sector. While the community remains divided between those viewing the post-earnings sell-off as a prime buying opportunity and others concerned about elevated valuations and China-related headwinds, many are actively monitoring the stock for a potential rebound as the company's long-term AI infrastructure thesis remains a core focus.

Boost Run, Inc. is a provider of scalable cloud infrastructure purpose-built for enterprise AI and high-performance computing workloads. The platform delivers GPU compute, CPU nodes, managed Kubernetes orchestration, and shared storage through an intuitive management console and a robust API layer, enabling organizations to provision and scale resources across thousands of nodes in minutes. The company was founded on September 5, 2025 and is headquartered in Northbrook, IL.

Boost Run Inc. - Ordinary Shares - Class A

Boost Run Inc.

Boost Run is trending after a stellar Q2 earnings report showcased a significant jump in contracted revenue and a massive pipeline, fueling investor optimism about its position as a key AI cloud infrastructure player. While the stock has seen high engagement and strong bullish sentiment due to its recurring revenue visibility and partnership with NVIDIA, some community members are debating potential volatility surrounding upcoming warrant redemption deadlines and institutional ownership trends.

Unusual Machines, Inc. is a development stage technology company, which engages in the provision of drone solutions with a focus on first-person view (FPV) technology. It offers products to entertainment, recreation, and competitive racing industries. The company was founded on July 11, 2019, and is headquartered in Orlando, FL.

Unusual Machines Inc

Unusual Machines is surging as investors react to new presidential tariffs on foreign drone imports aimed at boosting domestic supply chains and national security. The community is actively discussing the potential for government investment and contracts, with many focusing on the company's role as a key manufacturer for essential drone components within the defense sector.

Nu Holdings Ltd. is a holding company, which engages in the provision of digital banking services. The company was founded by David Vélez Osorno, Cristina Helena Zingaretti Junqueira, and Adam Edward Wible on February 26, 2016 and is headquartered in São Paulo, Brazil.

Nu Holdings Ltd - Ordinary Shares Class A

Nu Holdings Ltd

Nu Holdings is trending due to a surge in market activity following the announcement of a one-billion-dollar share repurchase program, which investors view as a signal of management confidence in the company's financial health despite recent analyst downgrades. The community is actively discussing the stock's valuation, comparing its long-term growth potential and fintech ecosystem efficiency against traditional banking competitors.

Amprius Technologies, Inc. engages in the development, manufacture, and market of lithium-ion batteries for mobility applications, including the aviation, electric vehicle and light electric vehicle industries. It operates through the following geographical segments: North America, EMEA, and Asia Pacific. The company was founded by Mark C. Platshon in 2008 and headquartered in Fremont, CA.

Amprius Technologies Inc

Amprius Technologies is attracting significant community attention as investors weigh the company's NDAA-compliant battery technology against broader drone sector volatility and recent supply chain developments. While the stock has faced downward pressure, bullish sentiment remains tied to robust institutional interest, expanding military and commercial order pipelines, and anticipation of upcoming earnings results as a key catalyst.

AeroVironment, Inc. is a defense technology company delivering integrated capabilities across air, land, sea, space, and cyber. The company develops and deploys autonomous systems, loitering munitions, counter-UAS technologies, space-based platforms, directed energy systems, and cyber and electronic warfare capabilities-built to meet the mission needs of today’s warfighter and tomorrow’s conflicts. At the core of these technologies lies AV_Halo, a modular, mission-ready suite of AI-powered software tools that empowers warfighters and enables full-battlefield dominance: detect, decide, deliver. With a national manufacturing footprint and a deep innovation pipeline, AV delivers proven systems and future-defining capabilities at speed, scale, and operational relevance. The company was founded by Paul B. MacCready, Jr. in July 1971 and is headquartered in Arlington, VA.

AeroVironment Inc.

AeroVironment is trending as traders analyze the impact of President Trump's new tariff program on foreign-made drones, which aims to boost domestic manufacturing and security. The community is actively discussing the stock's role in the defense sector, weighing government investment potential and defense contracts against recent price volatility.

York Space Systems, Inc. engages in providing a comprehensive suite of mission-critical solutions for national security, government, and commercial customers. It offers a vertically integrated, full technology stack of solutions including design, production, integration, and operation of spacecraft with turnkey offerings to manage spacecraft and constellations throughout the entire mission lifecycle. The company was founded by Dirk Wallinger in January 2012 and is headquartered in Denver, CO.

York Space Systems Inc

York Space Systems is drawing significant investor attention as it navigates a challenging earnings report and a recent downgrade, while simultaneously serving as a speculative focus for traders looking to capitalize on potential short squeezes and high short interest. The community remains deeply divided, with some betting on a rebound supported by government contract wins and defense sector tailwinds, while others express concern over management changes, revenue guidance cuts, and the impact of insider selling.

Palladyne AI Corp. engages in the design, development, and manufacture of industrial robotic systems that augment human performance by combining human intelligence, instinct, and judgment with the strength, endurance, and precision of machines to enhance employee safety and productivity. Its products include Palldyne IQ and Palladyne Pilot. The company was founded by Fraser M. Smith and Benjamin G. Wolff in 2015 and is headquartered in Salt Lake City, UT.

Palladyne AI Corp.

Palladyne AI is trending as investors react to the company securing significant U.S. Army contracts for its SwarmOS technology and Gremlin-X UAV, validating its position in the defense autonomy sector. The community is actively discussing the stock's potential for a short squeeze due to high short interest, alongside excitement regarding the company's expanding backlog and partnerships with industry giants.

Sigma Lithium Corp. engages in the producing of a lithium property. It focuses its project in Minas Gerais. The firm also plans to build a world-class commercial-scale lithium concentration plant. The company was founded on June 8, 2011 and is headquartered in Sao Paulo, Brazil.

Sigma Lithium Corporation

Sigma Lithium is seeing heightened volatility as investors weigh strong production results and cash flow growth against a new short-seller report alleging regulatory risks and safety concerns. Community sentiment is deeply divided, with many shareholders dismissing the critical report as manipulation while others express frustration over management transparency and recent price performance.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$HRTX If we are talking about a buyout, I don&#39;t think there is any need to rush it if the BOD believes that the next few quarters could be more successful. There is currently hope that the pre syringed ZYN could be a game changer. However, CINVANTI should be sold at the earliest opportunity if the BOD sees a risk in the patent dispute and if a favorable situation arises for the sale.

Fred Garcia

StockTwits Web

Heron Therapeutics Inc

 If we are talking about a buyout, I don't think there is any need to rush it if the BOD believes that the next few quarters could be more successful. There is currently hope that the pre syringed ZYN could be a game changer. However, CINVANTI should be sold at the earliest opportunity if the BOD sees a risk in the patent dispute and if a favorable situation arises for the sale.

Don Genaro

@Stock765  
Problem is that the PS is more than a year away ....

  
Problem is that the PS is more than a year away ....

@Stock765 $HRTX  i dont agree that we keep waiting for long. The longer we wait the more the risk, the more the exposure. if this was sold earlier we wont have the Cinvanti problem, right? And who knows, scientist are working day and night to make everything better. We are better positioned to sell today than even tomorrow. Some company or scientist may come up with something that throws Zynrelef right into the bin. We need to get these pharmaceutical assets quickly into hands of big pharma who already have competitive advantage, so they can scale it &amp; bring out the best value from them at a much lower cost using their already established sales systems, channels and connection. We dont have so much time, except you want to see bankruptcy! I think Heron has tried to go by itself for too long, the aim for small biopharma is always to pursue a buyout as early as possible. Those that dont do get muscled up and eaten up eventually no matter how good the drugs they develop. Shorts know this.

  i dont agree that we keep waiting for long. The longer we wait the more the risk, the more the exposure. if this was sold earlier we wont have the Cinvanti problem, right? And who knows, scientist are working day and night to make everything better. We are better positioned to sell today than even tomorrow. Some company or scientist may come up with something that throws Zynrelef right into the bin. We need to get these pharmaceutical assets quickly into hands of big pharma who already have competitive advantage, so they can scale it & bring out the best value from them at a much lower cost using their already established sales systems, channels and connection. We dont have so much time, except you want to see bankruptcy! I think Heron has tried to go by itself for too long, the aim for small biopharma is always to pursue a buyout as early as possible. Those that dont do get muscled up and eaten up eventually no matter how good the drugs they develop. Shorts know this.